Resignation of Mrs. Ramya Ravi as the Company Secretary and Compliance Officer of the Company
Annual Secretarial Compliance Report for the year ended 31st March, 2026
Delay in financial results for the year ended 31st March, 2026
Resignation letter of Mr. Indirakumar
Outcome of the Rights Issue Committee Meeting held on 25th May, 2026
Outcome of the Rights issue Committee Meeting held on 28-04-2026.
Company has received an IT Demand Notice
Intimation of ISIN for Rights Entitlement to be credited for the purpose of Rights Issue of Indrayani Biotech Limited
Outcome of the Rights Issue Committee Meeting
Record date for the Partly Paid-up Rights Issue has been fixed as 28th April, 2026
| Particulars | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 49.25 | 42.31 | 40.44 | 39.09 | 44.38 | 31.53 | 30.81 | 17.32 | 50.57 | 29.10 | 35.95 | 35.01 |
| YOY Revenue Growth % | 185.55% | 65.08% | -3.84% | -15.01% | -9.88% | -25.49% | -23.81% | -55.7% | 13.95% | -7.69% | 16.67% | 102.18% |
| Other Income | 2.05 | 0.01 | 0.09 | 0.08 | 1.03 | 0.04 | 0.30 | 0.00 | 2.78 | 1.06 | 1.80 | 0.83 |
| Total Income | 51.30 | 42.32 | 40.53 | 39.18 | 45.41 | 31.57 | 31.11 | 17.32 | 53.35 | 30.16 | 37.75 | 35.85 |
| Total Expenses + | 49.45 | 42.70 | 34.99 | 38.09 | 40.68 | 30.63 | 29.92 | 16.89 | 61.66 | 29.95 | 36.69 | 35.70 |
| Cost of Materials Consumed | 31.84 | 28.16 | 24.52 | 24.44 | 26.10 | 16.67 | 17.09 | 10.05 | 38.96 | 20.76 | 21.94 | 26.10 |
| Employee Benefit Expense | 7.30 | 5.39 | 5.11 | 4.97 | 8.46 | 5.72 | 5.14 | 3.42 | 6.19 | 2.69 | 3.97 | 3.20 |
| Other Expenses | 6.93 | 6.24 | 3.52 | 6.23 | 5.73 | 4.25 | 5.69 | 0.85 | 9.93 | 3.47 | 7.59 | 2.93 |
| Operating Profit | -0.20 | -0.39 | 5.45 | 1.00 | 3.70 | 0.90 | 0.90 | 0.43 | -11.10 | -0.85 | -0.74 | -0.69 |
| OPM % | -0.4% | -0.9% | 13.5% | 2.6% | 8.3% | 2.9% | 2.9% | 2.5% | -21.9% | -2.9% | -2.1% | -2% |
| Profit Before Tax + | 1.85 | -0.38 | 5.54 | 1.08 | 4.73 | 0.94 | 1.20 | 0.43 | -8.32 | 0.21 | 1.06 | 0.14 |
| Tax Expense | 0.40 | 0.06 | 0.00 | 0.00 | 0.00 | 0.09 | -0.02 | 0.08 | 0.21 | 0.05 | 0.15 | 0.03 |
| Tax % | 21.8% | - | 0% | 0% | 0% | 10% | -1.5% | 18.8% | - | 25% | 14% | 18.9% |
| Profit After Tax | 1.44 | -0.45 | 5.54 | 1.08 | 4.73 | 0.85 | 1.22 | 0.35 | -8.53 | 0.16 | 0.91 | 0.12 |
| EPS (Basic) | 0.32 | -0.06 | 0.89 | 0.22 | 0.58 | 0.10 | 0.13 | 0.05 | -1.42 | 0.03 | 0.09 | 0.01 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Revenue from Operations | 130.23 | 166.23 | 162.93 | 61.57 | 21.09 |
| YOY Revenue Growth % | -21.66% | 2.02% | 164.61% | 191.97% | - |
| Other Income | 3.13 | 1.21 | 4.49 | 0.22 | 0.27 |
| Total Income | 133.35 | 167.44 | 167.41 | 61.79 | 21.35 |
| Total Expenses + | 139.10 | 156.47 | 154.61 | 57.34 | 28.46 |
| Cost of Materials Consumed | 82.77 | 103.22 | 102.21 | 41.04 | 15.77 |
| Employee Benefit Expense | 20.47 | 23.93 | 23.54 | 10.22 | 5.94 |
| Other Expenses | 20.73 | 21.72 | 19.95 | 3.54 | 4.33 |
| Operating Profit | -8.87 | 9.76 | 8.32 | 4.23 | -7.37 |
| OPM % | -6.8% | 5.9% | 5.1% | 6.9% | -35% |
| Profit Before Exceptional | -5.74 | 10.97 | 12.81 | 4.45 | -7.11 |
| Exceptional Items | 0.00 | 0.00 | -0.50 | 0.00 | -4.11 |
| Profit Before Tax + | -5.74 | 10.97 | 12.31 | 4.45 | -11.21 |
| Tax Expense | 0.36 | 0.55 | 0.38 | 0.01 | 0.00 |
| Tax % | - | 5% | 3% | 0.3% | - |
| Profit After Tax | -6.11 | 10.42 | 11.93 | 4.44 | -11.21 |
| EPS (Basic) | -1.35 | 1.40 | 2.55 | 1.30 | -3.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-Current Assets + | 90.23 | 90.05 | 78.44 | 30.46 | 30.43 |
| Property, Plant & Equipment | 34.34 | 39.08 | 34.11 | 12.67 | 11.53 |
| Capital Work in Progress | 25.67 | 20.30 | 13.74 | 13.27 | 13.72 |
| Non-Current Investments | 0.00 | 0.22 | 0.22 | 0.00 | 0.01 |
| Goodwill | 23.35 | 23.35 | 23.35 | 3.84 | 3.84 |
| Other Intangible Assets | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Current Assets + | 177.94 | 144.98 | 77.52 | 20.94 | 9.62 |
| Inventories | 41.34 | 42.35 | 12.21 | 1.53 | 1.09 |
| Trade Receivables | 58.69 | 39.53 | 29.97 | 14.10 | 4.77 |
| Cash and Cash Equivalents | 0.29 | 0.58 | 3.04 | 0.05 | 0.08 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | |||||
| Total Equity | 99.92 | 76.27 | 48.35 | 24.57 | 20.08 |
| Equity Share Capital | 45.54 | 45.54 | 43.48 | 34.23 | 34.23 |
| Other Equity | 26.97 | 21.68 | 11.61 | -10.06 | -14.51 |
| Non-Current Liabilities | 65.77 | 71.69 | 35.70 | 7.35 | 8.17 |
| Current Liabilities | 102.48 | 87.07 | 71.91 | 19.48 | 11.81 |
| Total Liabilities | 168.25 | 158.76 | 107.61 | 26.83 | 19.97 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Cash from Operating Activities | -6.74 | -30.35 | 16.19 | 4.13 | 0.26 |
| Cash from Investing Activities | 24.74 | -16.34 | -47.39 | -0.56 | -0.70 |
| Cash from Financing Activities | -18.30 | 44.24 | 32.74 | -2.74 | -0.28 |
| Net Increase/Decrease in Cash | -0.29 | -2.45 | 1.53 | 0.82 | -0.72 |